2011
DOI: 10.1007/s12272-011-0704-0
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells

Abstract: A series of 2-substituted-1,4-bis(dimethylamino)-9,10-anthraquinone derivatives were synthesized and their in vitro antiproliferative activities against p388 mouse leukemic tumor cells were evaluated. In addition, the effect of substituents on the phenyl ring was investigated. Among the derivatives tested, seven showed a high antiproliferative effect and three showed a moderate effect. In addition, introduction of a series of substituted phenyl groups into 1,4-bis(dimethylamino)-9,10-anthraquinone at 2-positio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 19 publications
0
5
0
Order By: Relevance
“…The analogue 29 showed an ED 50 value of 1.3 mg mL À1 while analogue 30 exhibited 1.5 mg mL À1 against the tested tumour cells. 59 Tu et al synthesized different anthraquinones derivatives that include 3-(3-alkylaminopropoxy)-9,10-anthraquinone and 1-hydroxy-3-(3-alkylaminopropoxy)-9,10-anthraquinone and evaluated their cytotoxicity towards different human cancer cell lines such as human urothelial carcinoma cells (NTUB1) and human prostate cancer cells (PC3). The derivatives 31 and 32 showed good anticancer activity against PC3 cells with IC 50 values of 7.64 and 8.89 mM, respectively.…”
Section: -2012mentioning
confidence: 99%
See 1 more Smart Citation
“…The analogue 29 showed an ED 50 value of 1.3 mg mL À1 while analogue 30 exhibited 1.5 mg mL À1 against the tested tumour cells. 59 Tu et al synthesized different anthraquinones derivatives that include 3-(3-alkylaminopropoxy)-9,10-anthraquinone and 1-hydroxy-3-(3-alkylaminopropoxy)-9,10-anthraquinone and evaluated their cytotoxicity towards different human cancer cell lines such as human urothelial carcinoma cells (NTUB1) and human prostate cancer cells (PC3). The derivatives 31 and 32 showed good anticancer activity against PC3 cells with IC 50 values of 7.64 and 8.89 mM, respectively.…”
Section: -2012mentioning
confidence: 99%
“…The analogue 29 showed an ED 50 value of 1.3 μg mL −1 while analogue 30 exhibited 1.5 μg mL −1 against the tested tumour cells. 59 …”
Section: Development Of Non-specific Cytotoxic Anthraquinone Derivativesmentioning
confidence: 99%
“…6 Several anthraquinone derivatives showing important biological activities have been reported. [7][8][9][10] Anthraquinone derivatives containing amines, amides, [11][12][13][14][15] pyrrole, and thiophene ring fused systems 16a show significantly increased cytotoxicity and are used as anti-proliferative agents in cancer therapy (Fig. 1).…”
Section: Introductionmentioning
confidence: 99%
“…From the data above, phenolic 2 was identified as a new compound, anthracene-2,4,9-triol. The known phenolics were identified, by comparing of their spectroscopic data with data previously reported in the literature, as (−)-catechin ( 3 ) [14], (−)-epiafzelechin ( 4 ) [14], (−)-epicatechin ( 5 ) [18], (−)-afzelechin ( 6 ) [18], naphthalen-2-ol ( 7 ) [19] and 7-hydroxy-5,4'-dimethoxy-2-arylbenzofuran ( 8 ) [15].…”
Section: Resultsmentioning
confidence: 99%